On 2025-05-07, Rhythm Pharmaceuticals, Inc. (RYTM) announced earnings per share of $-0.81 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.69.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.64 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-0.69 | $-0.81 |
| 2025-02-26 | 2024-12-31 | $-0.69 | $-0.72 |
| 2024-11-05 | 2024-09-30 | $-0.80 | $-0.73 |
| 2024-08-06 | 2024-06-30 | $-0.70 | $-0.55 |
| 2024-05-07 | 2024-03-31 | $-2.34 | $-2.35 |
| 2024-02-22 | 2023-12-31 | $-0.70 | $-0.70 |
| 2023-11-07 | 2023-09-30 | $-0.76 | $-0.76 |
| 2023-08-01 | 2023-06-30 | $-0.80 | $-0.82 |
| 2023-05-02 | 2023-03-31 | $-0.71 | $-0.92 |
| 2023-03-01 | 2022-12-31 | $-0.82 | $-0.75 |
| 2022-11-08 | 2022-09-30 | $-1.01 | $-0.79 |
| 2022-08-02 | 2022-06-30 | $-0.79 | $-0.89 |
| 2022-05-03 | 2022-03-31 | $-0.98 | $-1.05 |
| 2022-03-01 | 2021-12-31 | $-1.00 | $-0.85 |
| 2021-11-02 | 2021-09-30 | $-0.84 | $-0.70 |
| 2021-08-03 | 2021-06-30 | $-0.75 | $-0.70 |
| 2021-05-03 | 2021-03-31 | $-0.02 | $0.90 |
| 2021-03-01 | 2020-12-31 | $-0.81 | $-0.79 |
| 2020-11-02 | 2020-09-30 | $-0.83 | $-0.77 |
| 2020-08-03 | 2020-06-30 | $-0.83 | $-0.71 |
| 2020-05-04 | 2020-03-31 | $-0.80 | $-0.78 |
| 2020-03-02 | 2019-12-31 | $-0.91 | $-0.78 |
| 2019-11-01 | 2019-09-30 | $-1.05 | $-1.04 |
| 2019-07-29 | 2019-06-30 | $-0.81 | $-1.24 |
| 2019-05-03 | 2019-03-31 | $-0.69 | $-0.84 |
| 2019-03-08 | 2018-12-31 | $-0.56 | $-0.74 |
| 2018-11-09 | 2018-09-30 | $-0.41 | $-0.52 |
| 2018-08-08 | 2018-06-30 | $-0.40 | $-0.52 |
| 2018-05-14 | 2018-03-31 | $-0.45 | $-0.60 |
| 2018-03-12 | 2017-12-31 | $-0.55 | $-0.41 |
| 2017-11-14 | 2017-09-30 | $-0.56 | $-1.78 |